Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vishnu Chemicals Limited (VISHNU.NS)
Hyderabad, IN
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals, including sodium dichromate, chromic acid, chrome oxide green, basic chromium sulfate, sodium sulfate, and potassium dichromate, alongside barium carbonate. These essential chemicals serve a broad spectrum of industries, finding critical applications in pharmaceuticals, pigments, sports surfacing, leather processing, construction materials (such as equipment, roofing, and ceramic tiles), the automotive sector, decorative and functional plating, detergents, textiles, refractory brick production, and timber preservation. With its operational base in India, Vishnu Chemicals maintains a significant international footprint, supplying its offerings across Asia (including China and Southeast Asia), Europe (encompassing the United Kingdom), North America, South and Central America, Africa, and other worldwide markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.02% | +2.61% | +0.39% | +23.54% | +19.69% | +14.66% | +14.84% | +89.93% | +724.03% | +1,106.21% | +1,670.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+11.3% ★ Q1'26: +14.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+9.9% Q1'26: +9.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+0.6% Q1'26: +1.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+13.1% ★ Q1'26: +14.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.2% ★ Q1'26: +12.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+2.7% Q1'26: +2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.09× Q1'26: 1.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.59B
est: 5.06B (+50.1%)
|
6.67B
est: 7.28B (-8.3%)
|
6.72B
est: 8.08B (-16.8%)
|
10.66B
est: 10.35B (+3.0%)
|
13.88B
est: 14.15B (-1.9%)
|
12.09B
est: 16.57B (-27.0%)
|
14.47B
est: 14.36B (+0.7%)
|
15.55B
15.55B – 15.55B
+8.3% YoY
|
17.92B
17.92B – 17.92B
+15.3% YoY
|
19.71B
19.71B – 19.71B
+10.0% YoY
|
| EBITDA |
1.03B
est: 790.08M (+30.4%)
|
852.85M
est: 1.14B (-25.0%)
|
788.61M
est: 1.26B (-37.5%)
|
1.60B
est: 547.21M (+192.2%)
|
2.44B
est: 2.21B (+10.5%)
|
2.05B
est: 2.59B (-20.9%)
|
2.44B
est: 2.24B (+8.6%)
|
2.43B
2.43B – 2.43B
+8.3% YoY
|
2.80B
2.80B – 2.80B
+15.3% YoY
|
3.08B
3.08B – 3.08B
+10.0% YoY
|
| EBIT |
821.59M
est: 663.73M (+23.8%)
|
621.06M
est: 955.30M (-35.0%)
|
585.63M
est: 1.06B (-44.8%)
|
1.37B
est: 873.65M (+56.7%)
|
2.19B
est: 1.86B (+17.8%)
|
1.71B
est: 2.18B (-21.3%)
|
2.06B
est: 1.89B (+9.0%)
|
2.04B
2.04B – 2.04B
+8.3% YoY
|
2.35B
2.35B – 2.35B
+15.3% YoY
|
2.59B
2.59B – 2.59B
+10.0% YoY
|
| Net Income |
243.64M
est: 352.62M (-30.9%)
|
222.29M
est: 174.28M (+27.5%)
|
344.95M
est: 215.95M (+59.7%)
|
813.93M
est: 330.49M (+146.3%)
|
1.37B
est: 1.73B (-21.2%)
|
1.01B
est: 2.21B (-54.3%)
|
1.27B
est: 1.19B (+6.8%)
|
1.29B
1.29B – 1.29B
+8.8% YoY
|
1.80B
1.80B – 1.80B
+39.6% YoY
|
2.29B
2.29B – 2.29B
+26.9% YoY
|
| SGA |
115.78M
est: 524.18M (-77.9%)
|
124.22M
est: 1.53B (-91.9%)
|
754.05M
est: 837.44M (-10.0%)
|
1.30B
est: 2.43B (-46.5%)
|
1.37B
est: 3.26B (-57.9%)
|
1.04B
est: 1.72B (-39.4%)
|
1.44B
est: 1.49B (-3.6%)
|
1.61B
1.61B – 1.61B
+8.3% YoY
|
1.86B
1.86B – 1.86B
+15.3% YoY
|
2.04B
2.04B – 2.04B
+10.0% YoY
|
| EPS |
4.08
est: 5.38 (-24.2%)
|
3.72
est: 2.66 (+39.8%)
|
5.78
est: 3.30 (+75.4%)
|
13.63
est: 16.88 (-19.3%)
|
22.86
est: 26.46 (-13.6%)
|
15.90
est: 33.74 (-52.9%)
|
19.23
est: 18.10 (+6.2%)
|
19.70
19.70 – 19.70
+8.8% YoY
|
27.50
27.50 – 27.50
+39.6% YoY
|
34.90
34.90 – 34.90
+26.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cherukuri Krishna Murthy | Chairman & MD | 19M | male |
| Cherukuri Siddartha | Joint MD & Whole Time Director | 7M | male |
| T. Ramakrishna | Director of Commercial & Corporate Affairs | 2M | male |
| Vibha Shinde | Company Secretary & Compliance Officer | — | female |
| Kamalakara Rao | Director of Operations | — | male |
| Hanumant Bhansali | Vice President of Finance & Strategic Planning | — | male |
| Mahesh Bhatter | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VISHNU.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
